Terns Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.00
|
|
Average Rating
|
3.75
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.52
|
-0.44
|
0.08
|
15.38%
|
|
2022-06-30
|
-0.59
|
-0.55
|
0.04
|
6.78%
|
|
2022-03-31
|
-0.64
|
-0.55
|
0.09
|
14.06%
|
|
2021-12-31
|
-0.63
|
-0.56
|
0.07
|
11.11%
|
|
2021-09-30
|
-0.60
|
-0.47
|
0.13
|
21.67%
|
|
2021-06-30
|
-0.71
|
-0.43
|
0.28
|
39.44%
|
|
2021-03-31
|
-0.77
|
-0.88
|
-0.11
|
-14.29%
|
|
2020-12-31
|
-0.91
|
-30.94
|
-30.03
|
-3300.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.54
|
|
2021-12-31
|
-2.34
|
|
2020-12-31
|
-30.94
|